The current price of FGEN is $9.07 — it has decreased by 1.63% since the previous close. Data as of Jan 12, 2026.
FGEN is flat over the past week, flat over the past month and down 23.72% over the past year. The price is above its 200-day moving average of $8.84.
Analysts' average 12-month price target for FGEN is $28.00, which implies 208.71% upside from the current price. Individual estimates range from $28.00 to $28.00.
Of the 1 analyst covering FibroGen, Inc., 1 rates it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
FibroGen, Inc. has a market capitalization of $36.69M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
FibroGen, Inc. has not paid any dividends over the past year.
In the latest trading session FGEN moved between $9.02 and $9.21, a range of 2.09% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of FibroGen, Inc. shows a buy rating today and a neutral rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for FibroGen, Inc. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks FGEN has traded between $7.99 and $11.19. The current price is 18.95% below its 52-week high.
Figures as of Jan 12, 2026. This information is provided for general purposes only and is not investment advice.